25 XP   0   0   10

MeVis Medical Solutions AG
Buy, Hold or Sell?

Let's analyse Mevis together

PenkeI guess you are interested in MeVis Medical Solutions AG. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of MeVis Medical Solutions AG. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about MeVis Medical Solutions AG

I send you an email if I find something interesting about MeVis Medical Solutions AG.

Quick analysis of Mevis (30 sec.)










What can you expect buying and holding a share of Mevis? (30 sec.)

How much money do you get?

How much money do you get?
€18.32
When do you have the money?
1 year
How often do you get paid?
80.0%

What is your share worth?

Current worth
€9.79
Expected worth in 1 year
€9.79
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
€17.12
Return On Investment
67.4%

For what price can you sell your share?

Current Price per Share
€25.40
Expected price per share
€25.15 - €28.23
How sure are you?
50%

1. Valuation of Mevis (5 min.)




Live pricePrice per Share (EOD)

€25.40

Intrinsic Value Per Share

€25.09 - €55.12

Total Value Per Share

€34.89 - €64.91

2. Growth of Mevis (5 min.)




Is Mevis growing?

Current yearPrevious yearGrowGrow %
How rich?$19m$19m0.000.0%

How much money is Mevis making?

Current yearPrevious yearGrowGrow %
Making money$5.2m$8.3m-$3m-58.3%
Net Profit Margin28.4%41.5%--

How much money comes from the company's main activities?

3. Financial Health of Mevis (5 min.)




4. Comparing to competitors in the Health Information Services industry (5 min.)




  Industry Rankings (Health Information Services)  


Richest
#73 / 120

Most Revenue
#58 / 120

Most Profit
#23 / 120

What can you expect buying and holding a share of Mevis? (5 min.)

Welcome investor! Mevis's management wants to use your money to grow the business. In return you get a share of Mevis.

What can you expect buying and holding a share of Mevis?

First you should know what it really means to hold a share of Mevis. And how you can make/lose money.

Speculation

The Price per Share of Mevis is €25.40. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Mevis.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Mevis, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €9.79. Based on the TTM, the Book Value Change Per Share is €0.00 per quarter. Based on the YOY, the Book Value Change Per Share is €0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €4.28 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Mevis.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps2.8911.4%2.8911.4%4.5818.0%3.6514.4%3.6414.3%
Usd Book Value Change Per Share0.000.0%0.000.0%0.000.0%-1.67-6.6%1.054.1%
Usd Dividend Per Share4.5818.0%4.5818.0%2.6710.5%2.509.8%1.817.1%
Usd Total Gains Per Share4.5818.0%4.5818.0%2.6710.5%0.823.2%2.8611.2%
Usd Price Per Share29.97-29.97-35.96-33.13-32.35-
Price to Earnings Ratio10.36-10.36-7.85-9.57-9.13-
Price-to-Total Gains Ratio6.54-6.54-13.45-12.67--18.14-
Price to Book Ratio2.86-2.86-3.43-3.16-2.41-
Price-to-Total Gains Ratio6.54-6.54-13.45-12.67--18.14-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share27.18308
Number of shares36
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share4.582.50
Usd Book Value Change Per Share0.00-1.67
Usd Total Gains Per Share4.580.82
Gains per Quarter (36 shares)164.8829.62
Gains per Year (36 shares)659.54118.47
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
16600650360-241108
2131901310719-482226
31979019701079-723344
42638026301438-964462
53298032901798-1205580
63957039502157-1446698
74617046102517-1687816
85276052702876-1928934
95936059303236-21691052
106595065903595-24101170

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%
Book Value Change Per Share0.00.01.00.0%0.00.03.00.0%0.02.03.00.0%2.05.03.020.0%2.05.03.020.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.02.080.0%8.00.02.080.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%7.03.00.070.0%7.03.00.070.0%

Fundamentals of Mevis

About MeVis Medical Solutions AG

MeVis Medical Solutions AG develops, markets, and sells software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company's clinical focuses are image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. It offers X-ray based radiography procedures, including computed tomography, mammography/digital tomosynthesis, magnetic resonance imaging, and digital sonography; and provides services in the field of software programming for medical technology companies, which comprise provision of software developers, product and project managers, application specialists, and test engineers. The company also offers three-dimensional technical visualizations; and interactive online training to enhance the diagnostic skills of clinicians, as well as internet-based special applications in teleradiology. In addition, it develops and sells software licenses; and provides services for technical visualization and online training. The company was incorporated in 1997 and is based in Bremen, Germany. MeVis Medical Solutions AG is a subsidiary of Varex Imaging Deutschland AG.

Fundamental data was last updated by Penke on 2024-04-10 08:18:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of MeVis Medical Solutions AG.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Mevis earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Mevis to the Health Information Services industry mean.
  • A Net Profit Margin of 28.4% means that €0.28 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of MeVis Medical Solutions AG:

  • The MRQ is 28.4%. The company is making a huge profit. +2
  • The TTM is 28.4%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ28.4%TTM28.4%0.0%
TTM28.4%YOY41.5%-13.1%
TTM28.4%5Y35.2%-6.8%
5Y35.2%10Y36.2%-1.0%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ28.4%-21.3%+49.7%
TTM28.4%-20.1%+48.5%
YOY41.5%-29.8%+71.3%
5Y35.2%-36.1%+71.3%
10Y36.2%-42.2%+78.4%
1.1.2. Return on Assets

Shows how efficient Mevis is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Mevis to the Health Information Services industry mean.
  • 17.5% Return on Assets means that Mevis generated €0.18 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of MeVis Medical Solutions AG:

  • The MRQ is 17.5%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 17.5%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ17.5%TTM17.5%0.0%
TTM17.5%YOY25.0%-7.4%
TTM17.5%5Y22.7%-5.1%
5Y22.7%10Y18.5%+4.2%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ17.5%-6.5%+24.0%
TTM17.5%-6.0%+23.5%
YOY25.0%-5.4%+30.4%
5Y22.7%-5.3%+28.0%
10Y18.5%-7.4%+25.9%
1.1.3. Return on Equity

Shows how efficient Mevis is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Mevis to the Health Information Services industry mean.
  • 27.6% Return on Equity means Mevis generated €0.28 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of MeVis Medical Solutions AG:

  • The MRQ is 27.6%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 27.6%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ27.6%TTM27.6%0.0%
TTM27.6%YOY43.7%-16.1%
TTM27.6%5Y34.8%-7.2%
5Y34.8%10Y26.8%+8.0%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ27.6%-6.8%+34.4%
TTM27.6%-6.8%+34.4%
YOY43.7%-6.7%+50.4%
5Y34.8%-8.4%+43.2%
10Y26.8%-9.6%+36.4%

1.2. Operating Efficiency of MeVis Medical Solutions AG.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Mevis is operating .

  • Measures how much profit Mevis makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Mevis to the Health Information Services industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of MeVis Medical Solutions AG:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY34.5%-34.5%
TTM-5Y27.5%-27.5%
5Y27.5%10Y31.3%-3.9%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ--22.7%+22.7%
TTM--16.4%+16.4%
YOY34.5%-22.8%+57.3%
5Y27.5%-18.4%+45.9%
10Y31.3%-31.6%+62.9%
1.2.2. Operating Ratio

Measures how efficient Mevis is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Health Information Services industry mean).
  • An Operation Ratio of 0.74 means that the operating costs are €0.74 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of MeVis Medical Solutions AG:

  • The MRQ is 0.743. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.743. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.743TTM0.7430.000
TTM0.743YOY0.700+0.043
TTM0.7435Y0.788-0.045
5Y0.78810Y0.883-0.095
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7431.370-0.627
TTM0.7431.385-0.642
YOY0.7001.389-0.689
5Y0.7881.398-0.610
10Y0.8831.349-0.466

1.3. Liquidity of MeVis Medical Solutions AG.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Mevis is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Health Information Services industry mean).
  • A Current Ratio of 1.66 means the company has €1.66 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of MeVis Medical Solutions AG:

  • The MRQ is 1.660. The company is able to pay all its short-term debts. +1
  • The TTM is 1.660. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.660TTM1.6600.000
TTM1.660YOY4.779-3.118
TTM1.6605Y8.000-6.339
5Y8.00010Y5.276+2.723
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6601.811-0.151
TTM1.6601.820-0.160
YOY4.7792.055+2.724
5Y8.0002.589+5.411
10Y5.2762.589+2.687
1.3.2. Quick Ratio

Measures if Mevis is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Mevis to the Health Information Services industry mean.
  • A Quick Ratio of 0.39 means the company can pay off €0.39 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of MeVis Medical Solutions AG:

  • The MRQ is 0.387. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.387. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.387TTM0.3870.000
TTM0.387YOY1.333-0.946
TTM0.3875Y2.117-1.730
5Y2.11710Y1.422+0.695
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3871.152-0.765
TTM0.3871.241-0.854
YOY1.3331.723-0.390
5Y2.1172.117+0.000
10Y1.4222.107-0.685

1.4. Solvency of MeVis Medical Solutions AG.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Mevis assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Mevis to Health Information Services industry mean.
  • A Debt to Asset Ratio of 0.36 means that Mevis assets are financed with 36.5% credit (debt) and the remaining percentage (100% - 36.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of MeVis Medical Solutions AG:

  • The MRQ is 0.365. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.365. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.365TTM0.3650.000
TTM0.365YOY0.429-0.064
TTM0.3655Y0.352+0.013
5Y0.35210Y0.297+0.055
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3650.379-0.014
TTM0.3650.381-0.016
YOY0.4290.399+0.030
5Y0.3520.411-0.059
10Y0.2970.453-0.156
1.4.2. Debt to Equity Ratio

Measures if Mevis is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Mevis to the Health Information Services industry mean.
  • A Debt to Equity ratio of 57.4% means that company has €0.57 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of MeVis Medical Solutions AG:

  • The MRQ is 0.574. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.574. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.574TTM0.5740.000
TTM0.574YOY0.750-0.177
TTM0.5745Y0.554+0.020
5Y0.55410Y0.440+0.114
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5740.584-0.010
TTM0.5740.575-0.001
YOY0.7500.607+0.143
5Y0.5540.709-0.155
10Y0.4400.616-0.176

2. Market Valuation of MeVis Medical Solutions AG

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Mevis generates.

  • Above 15 is considered overpriced but always compare Mevis to the Health Information Services industry mean.
  • A PE ratio of 10.36 means the investor is paying €10.36 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of MeVis Medical Solutions AG:

  • The EOD is 9.397. Based on the earnings, the company is underpriced. +1
  • The MRQ is 10.359. Based on the earnings, the company is underpriced. +1
  • The TTM is 10.359. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD9.397MRQ10.359-0.962
MRQ10.359TTM10.3590.000
TTM10.359YOY7.851+2.508
TTM10.3595Y9.567+0.792
5Y9.56710Y9.135+0.433
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD9.397-1.331+10.728
MRQ10.359-2.188+12.547
TTM10.359-2.131+12.490
YOY7.851-3.487+11.338
5Y9.567-4.987+14.554
10Y9.135-4.494+13.629
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of MeVis Medical Solutions AG:

  • The EOD is 8.006. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 8.825. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 8.825. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD8.006MRQ8.825-0.819
MRQ8.825TTM8.8250.000
TTM8.825YOY12.944-4.119
TTM8.8255Y11.506-2.681
5Y11.50610Y10.126+1.380
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD8.006-1.376+9.382
MRQ8.825-1.754+10.579
TTM8.825-2.377+11.202
YOY12.944-5.605+18.549
5Y11.506-3.847+15.353
10Y10.126-3.463+13.589
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Mevis is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Health Information Services industry mean).
  • A PB ratio of 2.86 means the investor is paying €2.86 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of MeVis Medical Solutions AG:

  • The EOD is 2.593. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.859. Based on the equity, the company is underpriced. +1
  • The TTM is 2.859. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.593MRQ2.859-0.265
MRQ2.859TTM2.8590.000
TTM2.859YOY3.430-0.572
TTM2.8595Y3.161-0.302
5Y3.16110Y2.408+0.753
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD2.5931.760+0.833
MRQ2.8591.837+1.022
TTM2.8591.943+0.916
YOY3.4302.978+0.452
5Y3.1613.997-0.836
10Y2.4084.198-1.790
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of MeVis Medical Solutions AG compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share----0%-0%-1.5640%0.979-100%
Book Value Per Share--9.7959.7950%9.7950%9.7950%13.769-29%
Current Ratio--1.6601.6600%4.779-65%8.000-79%5.276-69%
Debt To Asset Ratio--0.3650.3650%0.429-15%0.352+4%0.297+23%
Debt To Equity Ratio--0.5740.5740%0.750-24%0.554+4%0.440+30%
Dividend Per Share--4.2804.2800%2.498+71%2.333+83%1.689+153%
Eps--2.7032.7030%4.280-37%3.410-21%3.402-21%
Free Cash Flow Per Share--3.1733.1730%2.596+22%3.155+1%3.245-2%
Free Cash Flow To Equity Per Share--3.1733.1730%0.098+3131%1.678+89%1.306+143%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--55.120--------
Intrinsic Value_10Y_min--25.093--------
Intrinsic Value_1Y_max--4.013--------
Intrinsic Value_1Y_min--3.024--------
Intrinsic Value_3Y_max--13.208--------
Intrinsic Value_3Y_min--8.698--------
Intrinsic Value_5Y_max--23.791--------
Intrinsic Value_5Y_min--13.905--------
Market Cap46228000.000-10%50960000.00050960000.0000%61152000.000-17%56347200.000-10%55016052.000-7%
Net Profit Margin--0.2840.2840%0.415-32%0.352-19%0.362-22%
Operating Margin----0%0.345-100%0.275-100%0.313-100%
Operating Ratio--0.7430.7430%0.700+6%0.788-6%0.883-16%
Pb Ratio2.593-10%2.8592.8590%3.430-17%3.161-10%2.408+19%
Pe Ratio9.397-10%10.35910.3590%7.851+32%9.567+8%9.135+13%
Price Per Share25.400-10%28.00028.0000%33.600-17%30.960-10%30.229-7%
Price To Free Cash Flow Ratio8.006-10%8.8258.8250%12.944-32%11.506-23%10.126-13%
Price To Total Gains Ratio5.935-10%6.5436.5430%13.453-51%12.665-48%-18.138+377%
Quick Ratio--0.3870.3870%1.333-71%2.117-82%1.422-73%
Return On Assets--0.1750.1750%0.250-30%0.227-23%0.185-5%
Return On Equity--0.2760.2760%0.437-37%0.348-21%0.268+3%
Total Gains Per Share--4.2804.2800%2.498+71%0.769+457%2.669+60%
Usd Book Value--19077407.43919077407.4390%19077407.4390%19077407.7000%26817939.010-29%
Usd Book Value Change Per Share----0%-0%-1.6740%1.048-100%
Usd Book Value Per Share--10.48210.4820%10.4820%10.4820%14.735-29%
Usd Dividend Per Share--4.5804.5800%2.673+71%2.497+83%1.808+153%
Usd Eps--2.8932.8930%4.580-37%3.649-21%3.641-21%
Usd Free Cash Flow--6179779.1796179779.1790%5056028.105+22%6144713.916+1%6321056.078-2%
Usd Free Cash Flow Per Share--3.3953.3950%2.778+22%3.376+1%3.473-2%
Usd Free Cash Flow To Equity Per Share--3.3953.3950%0.105+3131%1.796+89%1.398+143%
Usd Market Cap49473205.600-10%54537392.00054537392.0000%65444870.400-17%60302773.440-10%58878178.850-7%
Usd Price Per Share27.183-10%29.96629.9660%35.959-17%33.133-10%32.351-7%
Usd Profit--5264898.1615264898.1610%8335839.020-37%6641473.294-21%6578104.387-20%
Usd Revenue--18559408.40018559408.4000%20079092.400-8%18733291.928-1%18117564.344+2%
Usd Total Gains Per Share--4.5804.5800%2.673+71%0.823+457%2.856+60%
 EOD+4 -4MRQTTM+0 -0YOY+14 -165Y+13 -2010Y+12 -23

3.2. Fundamental Score

Let's check the fundamental score of MeVis Medical Solutions AG based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-159.397
Price to Book Ratio (EOD)Between0-12.593
Net Profit Margin (MRQ)Greater than00.284
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.387
Current Ratio (MRQ)Greater than11.660
Debt to Asset Ratio (MRQ)Less than10.365
Debt to Equity Ratio (MRQ)Less than10.574
Return on Equity (MRQ)Greater than0.150.276
Return on Assets (MRQ)Greater than0.050.175
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of MeVis Medical Solutions AG based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5066.458
Ma 20Greater thanMa 5024.380
Ma 50Greater thanMa 10024.106
Ma 100Greater thanMa 20023.737
OpenGreater thanClose25.600
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets28,054
Total Liabilities10,228
Total Stockholder Equity17,826
 As reported
Total Liabilities 10,228
Total Stockholder Equity+ 17,826
Total Assets = 28,054

Assets

Total Assets28,054
Total Current Assets11,371
Long-term Assets16,683
Total Current Assets
Cash And Cash Equivalents 7,744
Net Receivables 2,652
Other Current Assets 314
Total Current Assets  (as reported)11,371
Total Current Assets  (calculated)10,709
+/- 661
Long-term Assets
Property Plant Equipment 146
Long-term Assets  (as reported)16,683
Long-term Assets  (calculated)146
+/- 16,537

Liabilities & Shareholders' Equity

Total Current Liabilities6,849
Long-term Liabilities3,379
Total Stockholder Equity17,826
Total Current Liabilities
Accounts payable 77
Total Current Liabilities  (as reported)6,849
Total Current Liabilities  (calculated)77
+/- 6,772
Long-term Liabilities
Long-term Liabilities  (as reported)3,379
Long-term Liabilities  (calculated)0
+/- 3,379
Total Stockholder Equity
Retained Earnings 4,540
Total Stockholder Equity (as reported)17,826
Total Stockholder Equity (calculated)4,540
+/- 13,286
Other
Capital Stock1,820
Common Stock Shares Outstanding 1,820
Net Invested Capital 17,826
Net Working Capital 4,522
Property Plant and Equipment Gross 1,991



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2023-09-302022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-302015-09-302014-09-30
> Total Assets 
38,254
45,549
43,003
49,079
38,419
23,920
27,791
27,534
31,201
28,054
28,05431,20127,53427,79123,92038,41949,07943,00345,54938,254
   > Total Current Assets 
20,688
28,720
26,904
33,414
7,051
7,026
11,008
10,774
14,369
11,371
11,37114,36910,77411,0087,0267,05133,41426,90428,72020,688
       Cash And Cash Equivalents 
9,267
25,621
24,356
29,735
3,477
2,600
3,954
7,621
9,320
7,744
7,7449,3207,6213,9542,6003,47729,73524,35625,6219,267
       Short-term Investments 
8,313
2
20
2
1
1
0
0
0
0
00001122028,313
       Net Receivables 
2,820
2,836
2,432
3,677
3,573
4,412
2,747
2,272
4,008
2,652
2,6524,0082,2722,7474,4123,5733,6772,4322,8362,820
       Other Current Assets 
83
60
30
0
0
14
409
354
262
314
3142623544091400306083
   > Long-term Assets 
0
0
0
15,665
31,264
16,799
16,734
16,659
16,699
16,683
16,68316,69916,65916,73416,79931,26415,665000
       Property Plant Equipment 
374
319
316
316
215
243
194
122
162
146
146162122194243215316316319374
       Goodwill 
10,625
10,625
10,625
10,625
10,625
0
0
0
0
0
0000010,62510,62510,62510,62510,625
       Long Term Investments 
1,571
1,718
1,611
1,991
312
312
0
0
0
0
00003123121,9911,6111,7181,571
       Intangible Assets 
4,996
3,229
2,093
1,097
492
18
2
0
0
0
0002184921,0972,0933,2294,996
       Other Assets 
0
938
1,454
1,636
16,329
16,320
16,274
16,325
16,359
0
016,35916,32516,27416,32016,3291,6361,4549380
> Total Liabilities 
7,984
11,820
10,114
16,568
6,360
6,094
9,965
9,708
13,375
10,228
10,22813,3759,7089,9656,0946,36016,56810,11411,8207,984
   > Total Current Liabilities 
5,382
11,671
9,845
16,267
4,210
3,974
404
2,365
3,007
6,849
6,8493,0072,3654043,9744,21016,2679,84511,6715,382
       Short-term Debt 
0
0
0
9,368
1,619
0
0
0
0
0
000001,6199,368000
       Short Long Term Debt 
0
0
0
9,368
1,619
0
0
0
0
0
000001,6199,368000
       Accounts payable 
579
553
327
279
29
11
93
240
193
77
77193240931129279327553579
       Other Current Liabilities 
3,988
9,759
7,908
13,939
1,711
861
170
760
1,009
0
01,0097601708611,71113,9397,9089,7593,988
   > Long-term Liabilities 
0
0
0
301
327
2,536
2,489
3,053
3,704
3,379
3,3793,7043,0532,4892,536327301000
       Long-term Liabilities Other 
0
0
0
0
0
49
35
39
0
0
0039354900000
> Total Stockholder Equity
30,270
33,729
32,889
32,511
32,059
17,826
17,826
17,826
17,826
17,826
17,82617,82617,82617,82617,82632,05932,51132,88933,72930,270
   Common Stock
1,820
1,820
1,820
1,820
1,820
1,820
1,820
1,820
1,820
0
01,8201,8201,8201,8201,8201,8201,8201,8201,820
   Retained Earnings 
21,305
23,298
22,524
22,990
4,545
4,545
4,545
4,545
4,545
4,540
4,5404,5454,5454,5454,5454,54522,99022,52423,29821,305
   Capital Surplus 0000000000
   Treasury Stock0000000000
   Other Stockholders Equity 
661
404
326
226
139
0
0
0
0
0
00000139226326404661



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2023-09-30)

Gross Profit (+$)
totalRevenue17,342
Cost of Revenue-445
Gross Profit16,89716,897
 
Operating Income (+$)
Gross Profit16,897
Operating Expense-12,437
Operating Income4,9054,460
 
Operating Expense (+$)
Research Development0
Selling General Administrative442
Selling And Marketing Expenses0
Operating Expense12,437442
 
Net Interest Income (+$)
Interest Income111
Interest Expense-43
Other Finance Cost-0
Net Interest Income68
 
Pretax Income (+$)
Operating Income4,905
Net Interest Income68
Other Non-Operating Income Expenses0
Income Before Tax (EBT)5,0344,905
EBIT - interestExpense = -43
4,920
4,962
Interest Expense43
Earnings Before Interest and Taxes (EBIT)05,077
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax5,034
Tax Provision-114
Net Income From Continuing Ops4,9204,920
Net Income4,920
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-68
 

Technical Analysis of Mevis
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Mevis. The general trend of Mevis is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Mevis's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of MeVis Medical Solutions AG.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 25.73 < 28.23 < 28.23.

The bearish price targets are: 25.35 > 25.35 > 25.15.

Tweet this
MeVis Medical Solutions AG Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of MeVis Medical Solutions AG. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

MeVis Medical Solutions AG Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of MeVis Medical Solutions AG. The current macd is 0.38646856.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Mevis price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Mevis. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Mevis price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
MeVis Medical Solutions AG Daily Moving Average Convergence/Divergence (MACD) ChartMeVis Medical Solutions AG Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of MeVis Medical Solutions AG. The current adx is 18.85.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Mevis shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
MeVis Medical Solutions AG Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of MeVis Medical Solutions AG. The current sar is 23.37.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
MeVis Medical Solutions AG Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of MeVis Medical Solutions AG. The current rsi is 66.46. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
MeVis Medical Solutions AG Daily Relative Strength Index (RSI) ChartMeVis Medical Solutions AG Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of MeVis Medical Solutions AG. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Mevis price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
MeVis Medical Solutions AG Daily Stochastic Oscillator ChartMeVis Medical Solutions AG Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of MeVis Medical Solutions AG. The current cci is 100.69.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
MeVis Medical Solutions AG Daily Commodity Channel Index (CCI) ChartMeVis Medical Solutions AG Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of MeVis Medical Solutions AG. The current cmo is 46.17.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
MeVis Medical Solutions AG Daily Chande Momentum Oscillator (CMO) ChartMeVis Medical Solutions AG Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of MeVis Medical Solutions AG. The current willr is -6.25.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
MeVis Medical Solutions AG Daily Williams %R ChartMeVis Medical Solutions AG Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of MeVis Medical Solutions AG.

MeVis Medical Solutions AG Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of MeVis Medical Solutions AG. The current atr is 0.31273979.

MeVis Medical Solutions AG Daily Average True Range (ATR) ChartMeVis Medical Solutions AG Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of MeVis Medical Solutions AG. The current obv is 201.00.

MeVis Medical Solutions AG Daily On-Balance Volume (OBV) ChartMeVis Medical Solutions AG Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of MeVis Medical Solutions AG. The current mfi is 82.64.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
MeVis Medical Solutions AG Daily Money Flow Index (MFI) ChartMeVis Medical Solutions AG Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for MeVis Medical Solutions AG.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-08BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-12ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-26ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-28ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-25MFI LONG ENTRY SHORT CLOSE80 crossover to upside

6.3. Candlestick Patterns

MeVis Medical Solutions AG Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of MeVis Medical Solutions AG based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5066.458
Ma 20Greater thanMa 5024.380
Ma 50Greater thanMa 10024.106
Ma 100Greater thanMa 20023.737
OpenGreater thanClose25.600
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Mevis with someone you think should read this too:
  • Are you bullish or bearish on Mevis? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Mevis? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about MeVis Medical Solutions AG

I send you an email if I find something interesting about MeVis Medical Solutions AG.


Comments

How you think about this?

Leave a comment

Stay informed about MeVis Medical Solutions AG.

Receive notifications about MeVis Medical Solutions AG in your mailbox!